NMR study of fumarprotocetraric acid, a complex lichen depsidone derivative from Cladonia furcata

Magnetic Resonance in Chemistry

Volumn 41, Issue 5, 2003, Pages 391-394

  Su, Bao Ning ^a   Cuendet, Muriel ^a   Nikolic, Dejan ^a   Kristinsson, Hördur ^b   Ingólfsdóttir, Kristín ^c   Van Breemen, Richard B ^a   Fong, Harry H S ^a   Pezzuto, John M ^a   Kinghorn, A Douglas ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Iceland Institute of Natural History   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

Author keywords

2D NMR; 13C NMR; 1H NMR; Cladonia furcata; Depsidone derivative; Fumarprotocetraric acid; Lichen; NMR; trans double bond; Triethylamine salt

Indexed keywords

FUNGI;

13C NMR; 1H NMR; 2-D NMR; CLADONIA; CLADONIUM FURCATUM; DEPSIDONE DERIVATIVE; FUMARPROTOCETRARIC ACID; LICHEN; TRANS-DOUBLE BONDS; TRIETHYLAMINE SALT; TRIETHYLAMINES;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; DEPSIDONE DERIVATIVE; FUMARPROTOCETRARIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; TRIETHYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL BOND; CLADONIA FURCATA; DRUG STRUCTURE; LICHEN; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS;

EID: 0038036860     PISSN: 07491581     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrc.1181     Document Type: Article

References (19)

1. Miao V, Coëffet-LeGal MF, Brown D, Sinnemann S, Donaldson G, Davies J. Trends Biotechnol. 2001; 19: 349.
2. Eifler-Lima VL, Sperry A, Sinbandhit S, Boustie J, Tomasi S, Schenkel E. Magn. Reson. Chem. 2000; 38: 472.
3. Mishchenko NP, Maximov OB, Krivoshchekova OE, Stepanenko LS. Phytochemistry 1984; 23: 180.
4. Elix JA, Wardlaw JH. Aust. J. Chem. 1999; 52: 713.
5. Chester DO, Elix JA. Aust. J. Chem. 1980; 33: 1153.
6. Wattenberg LW. Cancer Res. 1985; 45: 1.
7. Hong WK, Sporn MB. Science 1997; 278: 1073.
8. Waffo-Teguo P, Lee D, Cuendet M, Merillon JM, Pezzuto JM, Kinghorn AD. J. Nat. Prod. 2001; 64: 136.
9. Cuendet M, Pezzuto JM. Drug Metab. Drug Interact. 2000; 17: 109.
10. Kinghorn AD, Fong HHS, Farnsworth NR, Mehta RG, Moon RC, Moriarty RM, Pezzuto JM. Curr. Org. Chem. 1998; 2: 597.
11. Hesse O. J. Prakt. Chem. 1904; 70: 449.
12. Kartnig Th. Z. Phytother. 1987; 8: 127.
13. Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Nicklaus MC, Milne GWA, Proksa B, Pommier Y. J. Med. Chem. 1997; 40: 942.
14. Sundholm EG, Huneck S. Chem. Scr. 1981; 18: 233.
15. Keogh MF. Phytochemistry 1977; 16: 1102.
16. Karmali RA. Prostaglandins Med. 1980; 5: 11.
17. Levy GN. FASEB J. 1997; 11: 234.
18. Marnett LJ. Environ. Health Perspect. 1990; 88: 5.
19. Lupulescu A. Prostaglandins Leukotrienes Essent. Fatty Acids 1996; 54: 83.